Cho, J., Bass, A. J., Lawrence, M. S., Cibulskis, K., Cho, A., Lee, S., . . . Meyerson, M. (2014). Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab. BioMed Central.
Chicago-tyylinen lähdeviittausCho, Jeonghee, et al. Colon Cancer-derived Oncogenic EGFR G724S Mutant Identified By Whole Genome Sequence Analysis Is Dependent On Asymmetric Dimerization and Sensitive to Cetuximab. BioMed Central, 2014.
MLA-viiteCho, Jeonghee, et al. Colon Cancer-derived Oncogenic EGFR G724S Mutant Identified By Whole Genome Sequence Analysis Is Dependent On Asymmetric Dimerization and Sensitive to Cetuximab. BioMed Central, 2014.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.